DUBLIN, IRELAND--(MARKET WIRE)--Jun 21, 2007 -- Trinity Biotech plc (NasdaqGS:TRIB - News) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the launch of its new test for the detection of Legionella antigen in urine. The product is a rapid lateral flow test for the qualitative detection of Legionella pneumophilia in urine from patients with symptoms of pneumonia. The test can be performed by a health care professional and the result is obtained within 15 minutes.
